FDA Adverse Event Injury Summary report: N

AMPLATZER® TORQVUE® 45° DELIVERY SYSTEM

MDR report key: 1915106 · Received December 6, 2010

Report

Report Number
2135147-2010-00175
Event Type
Injury
Date Received
December 6, 2010
Date of Event
November 10, 2010
Report Date
December 6, 2010
Manufacturer
AGA MEDICAL CORPORATION
Product Code
DQY
PMA / PMN Number
K072313
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DELIVERY SYSTEM WAS DISCARDED SO WE ARE UNABLE TO PERFORM ANALYSIS TO INVESTIGATE THE REPORTED COMPLAINT. CONGENITAL ANOMALY/BIRTH DEFECT WAS CHECKED IN ERROR. "NO" SHOULD HAVE BEEN CHECKED (NOT "YES"). DELIVERY SYSTEM WAS DISCARDED.

Additional Manufacturer Narrative · 1

THE DELIVERY SYSTEM WAS DISCARDED SO WE ARE UNABLE TO PERFORM ANALYSIS TO INVESTIGATE THE REPORTED COMPLAINT. DELIVERY SYSTEM WAS DISCARDED.

Description of Event or Problem · 1

ACCORDING TO THE INITIAL INFORMATION RECEIVED, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION ON NOVEMBER 8 AND WAS ADMITTED TO THE CATH LAB TO CLOSE THE PATIENT'S VENTRICULAR SEPTAL DEFECT (VSD). DUE TO THE PATIENT'S DETERIORATING CONDITION, PERCUTANEOUS INTERVENTION WAS THE SOLE OPTION TO CLOSE THE VSD AS PHYSICIANS PREDICTED A 100% MORTALITY RISK SHOULD THE PATIENT UNDERGO SURGICAL INTERVENTION. A 26MM AMPLATZER SEPTAL OCCLUDER (ASO) WAS USED AND DEFORMED INTO A COBRA SHAPE UPON DEPLOYMENT. THE ASO WAS REMOVED AND A 28MM ASO WAS ATTEMPTED. (NOTE, THE USE OF AN ASO TO CLOSE A VSD REPRESENTS OFF-LABEL USE OF THE DEVICE.) DUE TO A KINK IN THE AMPLATZER TORQVUE 45° DELIVERY SYSTEM'S SHEATH (DTV45), THE 28MM ASO COULD NOT BE ADVANCED SO THE ASO WAS REMOVED AND THE DTV45 WAS DISCARDED. DUE TO THE PRESENCE OF INCREASING PERICARDIAL EFFUSION, WHICH WAS OBSERVED POST-PROCEDURE, THE PROCEDURE WAS ABORTED. THE PATIENT'S CONDITION WAS REPORTEDLY STABLE.

Description of Event or Problem · 1

ACCORDING TO THE INITIAL INFORMATION RECEIVED, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION ON NOVEMBER 8 AND WAS ADMITTED TO THE CATH LAB TO CLOSE THE PATIENT'S VENTRICULAR SEPTAL DEFECT (VSD). DUE TO THE PATIENT'S DETERIORATING CONDITION, PERCUTANEOUS INTERVENTION WAS THE SOLE OPTION TO CLOSE THE VSD AS PHYSICIANS PREDICTED A 100% MORTALITY RISK SHOULD THE PATIENT UNDERGO SURGICAL INTERVENTION. A 26MM AMPLATZER SEPTAL OCCLUDER (ASO) WAS USED AND DEFORMED INTO A COBRA SHAPE UPON DEPLOYMENT. THE ASO WAS REMOVED AND A 28MM ASO WAS ATTEMPTED. (NOTE, THE USE OF AN ASO TO CLOSE A VSD REPRESENTS OFF-LABEL USE OF THE DEVICE.) DUE TO A KINK IN THE AMPLATZER TORQVUE 45 DEGREES DELIVERY SYSTEM'S SHEATH (DTV45), THE 28MM ASO COULD NOT BE ADVANCED SO THE ASO WAS REMOVED AND THE DTV45 WAS DISCARDED. DUE TO THE PRESENCE OF INCREASING PERICARDIAL EFFUSION, WHICH WAS OBSERVED POST-PROCEDURE, THE PROCEDURE WAS ABORTED. THE PATIENT'S CONDITION WAS REPORTEDLY STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AMPLATZER® TORQVUE® 45° DELIVERY SYSTEM DELIVERY SYSTEM DQY AGA MEDICAL CORPORATION 9-ITV12F45/80

Patients

Seq Age Sex Outcome Treatment
1 75 YR Congenital Anomaly| R 9-ASD-028| 9-ASD-028| 9-ASD-026| 9-ASD-026